Eli Lilly Missed Expectations

Eli Lilly (LLY) reported earnings of $3.34 per share on revenue of $12.73 billion for the first quarter ended March 2025. The consensus earnings estimate was $3.52 per share on revenue of $12.64 billion. The Earnings Whisper number was $3.75 per share. The company missed expectations by 10.93% while revenue grew 45.17% on a year-over-year basis.

The company said it expects 2025 earnings of $20.78 to $22.28 per share and continues to expect revenue of $58.0 billion to $61.0 billion. The company's previous guidance was earnings of $22.50 to $24.00 per share and the current consensus earnings estimate is $22.43 per share on revenue of $59.82 billion for the year ending December 31, 2025.

Eli Lilly and Co is a drug manufacturing company. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.